Click to copyhttps://apnews.com/7ac3c601b39e44e8b53ae03ac10315b0
DUBLIN–(BUSINESS WIRE)–Jan 11, 2019–The “Gastrointestinal Diseases Drug Development Pipeline Review 2018” report has been added to ResearchAndMarkets.com’s offering.
Gastrointestinal Diseases Drug Development Pipeline Review, 2018 provides an overview of the pipeline landscape for gastrointestinal diseases.
It provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for gastroenteritis, enterocolitis, gastritis and peritonitis, and features dormant and discontinued products.
Gastroenteritis: There are 12 products in development for this indication.
Enterocolitis: There are 8 products in development for this indication.
Gastritis: There are 11 products in development for this indication.
Peritonitis: There are 7 products in development for this indication.
Molecular targets in development for gastrointestinal diseases include toll-like receptors, interleukin receptors and bacterial proteins. Companies operating in this pipeline space include Kyowa Hakko Kirin, RedHill Biopharma and GlaxoSmithKline.
Which companies are the most active within each pipeline?
Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
What are the most important R&D milestones and data publications to have happened in this disease area?
1 Table of Contents
3 Therapeutics Development
4 Therapeutics Assessment
5 Companies Involved in Therapeutics Development
6 Dormant Projects
7 Discontinued Products
8 Product Development Milestones
Avexegen Therapeutics Inc
BCWorld Pharm Co Ltd
Daewon Pharm Co Ltd
Daewoong Pharmaceutical Co Ltd
Infant Bacterial Therapeutics AB
Kyowa Hakko Kirin Co Ltd
Leadiant Biosciences Inc
Ology Bioservices Inc
ProMetic Life Sciences Inc
RedHill Biopharma Ltd
Regeneron Pharmaceuticals Inc
SynAct Pharma AB
Takeda Pharmaceutical Co Ltd
UMN Pharma Inc
For more information about this report visit https://www.researchandmarkets.com/research/vjw5x7/gastrointestinal?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20190111005122/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 01/11/2019 05:47 AM/DISC: 01/11/2019 05:47 AM